The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

The FDA approved the first generics of the direct oral anticoagulant rivaroxaban, the agency announced on Tuesday.

Our study is a step toward developing evidence-based clinical guidance to suggest apixaban as a safer choice than warfarin or ...

Half of renally-cleared rivaroxaban is cleared as unchanged drug and half as inactive metabolites. ‡Potent inhibitors of both CYP3A4 and P-gp include azole antifungals (e.g., ketoconazole ...

Lupin is introducing rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto. The medication is used to reduce the risk of major cardiovascular events in patients with coronary ...

Lupin announced that it has launched Rivaroxaban tablets USP, 2.5 mg, in the US market following final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug ...

Rivaroxaban is indicated for reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation • It is used for preventing deep vein thrombosis (DVT), which may ...

Discover the commercial and brand names of the generic drug Rivaroxaban. This indispensable guide is essential for healthcare professionals, patients, caregivers, and anyone seeking to understand ...